Concepedia

Molly S. Crowe

MS

Statistics

Publications

10

Citations

595

H-Index

10

Active since

2013

Affiliations

Virginia Commonwealth University(Current)

West Virginia University

Scripps Research Institute

RTI International

Indiana University Bloomington

Molly S. Crowe is an author at Virginia Commonwealth University specializing in pharmacology, medicine, and cannabinoid pharmacology.

Publications per year

2013–2019

10

Publications

10

A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects

Bogna M. Ignatowska‐Jankowska, Gemma L. Baillie, Steven G. Kinsey et al. · Neuropsychopharmacology · 2015 · 177 citations

, , +12

<i>In vivo</i> characterization of the highly selective monoacylglycerol lipase inhibitor <scp>KML</scp>29: antinociceptive activity without cannabimimetic side effects

Bogna M. Ignatowska‐Jankowska, Sudeshna Ghosh, Molly S. Crowe et al. · British Journal of Pharmacology · 2013 · 126 citations · Full text

, , +12

Branched Short-Chain Fatty Acid Isovaleric Acid Causes Colonic Smooth Muscle Relaxation via cAMP/PKA Pathway

Bryan A. Blakeney, Molly S. Crowe, Sunila Mahavadi et al. · Digestive Diseases and Sciences · 2018 · 73 citations · Full text

, , +8

Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain

Jenny L. Wilkerson, Sudeshna Ghosh, Deniz Bağdaş et al. · British Journal of Pharmacology · 2016 · 55 citations · Full text

, , +17

Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice

Molly S. Crowe, Emma Leishman, Matthew L. Banks et al. · British Journal of Pharmacology · 2014 · 44 citations · Full text

, , +17

1–5 of 10